The distribution of the pro-apoptotic protein Bax in the outer mitochondrial membrane (OMM) is a central point of regulation of apoptosis. It is now widely recognized that parts of the endoplasmic reticulum (ER) are closely associated to the OMM, and are actively involved in different signalling processes. We adressed a possible role of these domains, called Mitochondria-Associated Membranes 
Introduction
Apoptosis, the major programmed cell death pathway in animals, plays a central role during development, and along the whole life, by mediating the elimination of dispensable or potentially dangerous cells. Apoptosis is also involved in the response of cells to toxic molecules, such as antitumoral drugs. Apoptosis alterations are involved in developmental defects, tumor progression, and the resistance to anti-cancer treatments ( [1, 2] for reviews)
The permeabilization of the outer mitochondrial membrane (OMM) is a central event during the intrinsic pathway of apoptosis, that is normally activated by anti-tumoral treatments. It is controlled by proteins of the Bcl-2 family, among which the pro-apoptotic protein Bax is directly involved in the permeabilization process [3] . Following an apoptotic signal, Bax is redistributed from a mostly cytosolic to a mitochondrial localization that favors permeabilization. This redistribution is associated 1 to the exposure of hydrophobic domains [4] , the dimerization and the oligomerization of the protein [5] , and changes in the interactions with different partners, including anti-apoptotic proteins of the Bcl-2 family, BH3-only proteins, and other regulators such as the mitochondrial receptor Tomm22 ( [6] [7] [8] [9] for reviews).
Mitochondria-Associated Membranes (MAMs) are a domain of the endoplasmic reticulum (ER) that is in close contact with the OMM [10, 11] . They have been observed through microscopy and isolated as a membrane compartment containing elements from both ER and OMM. They are involved in biogenesis processes, like the biosynthesis and transfer of phospholipids from ER to mitochondria [12] , in signaling processes, like ceramide synthesis [13] and Ca
2+
-movements between ER and mitochondria [14] , or in degradation process, like mitophagy [15] . MAMs are dynamic structures that are done and undone, depending on the physiological status of the cell ( [16] [17] [18] for reviews).
We addressed a possible role of MAMs in Bax localization and redistribution in healthy cells and during apoptosis. Under certain conditions, a small proportion of Bax was found in ER [19, 20] . The hypothesis that MAMs stability could contribute to the regulation of Bax movements between different compartments thus deserves investigations. As underlined above, a difficulty comes from the fact that MAMs are not a stable well-defined compartment but are dependent on other cellular processes such as mitochondrial dynamics, Ca 2+ -signaling, or mitophagy. In mammalian cells, it is then difficult to evaluate the contribution of MAMs in Bax localization independently from these cellular processes, that also modulate apoptosis.
The heterologous expression of Bax, and other Bcl-2 family members, in yeast is a simplified cellular model tp investigate molecular mechanisms underlying the interaction of Bax with mitochondria [21] .
In yeast, MAMs stability depends on the ERMES complex (ER-Mitochondria Encounter Structure).
ERMES is formed of 4 proteins, Mmm1p, Mdm10p, Mdm12p and Mdm34p ( [22] , [17] for review). A fifth protein, Gem1p, belonging to the Miro family (Mitochondria Rho GTPase) contributes to the regulation of the complex [23] . The role of ERMES in lipid transfer between ER and OMM has been largely documented ([16] for review), but remains discussed [24] . Also, the role of individual proteins remains unclear. Furthermore, the deletion of MMM1, MDM10 or MDM12 genes leads to a dramatically altered phenotype, including a rapid loss of mitochondrial DNA, rendering functionnal studies difficult [25, 26] . However, the deletion of MDM34 leads to a marginally altered phenotype, with functional mitochondria (this study). We thus expressed Bax in a MDM34-null mutant, to evaluate the dependence of Bax localization and function on MAMs stability. Our results show that Bax 2 mitochondrial localization is decreased when MAMs were destabilized through the deletion of MDM34. Furthermore, we observed a pool of incompletely released, MAMs-associated cytochrome c, the size of which was decreased in the Δmdm34 strain.
Experimental procedures
The deletion cassettes of ERMES genes from the Euroscarf collection were amplified by PCR, transferred into the W303-1A strain by homologous recombination and selection for G418 resistance, and verified by PCR with primers located within the KanMX4 gene and in the 5' and 3' sequences of ERMES gene. Like reported by others [26] , the deletion of MMM1, MDM10 or MDM12 led to a rapid loss of mitochondrial DNA (rho-/0 genotype), making these strains useless for our studies. However, we could generate stable rho+ strains deleted for MDM34.
Wild type W303-1A (mata, ade2, his3, leu2, trp1, ura3) and the mutant Δmdm34::kanMX4 were transformed with plasmids pYES3-BaxWT, pYES3-BaxP168A, or pYES3-BaxS184V [27, 28] . Cotransformations with the plasmid pYES2-Bcl-xL were also done. Crude mitochondria fractions were isolated from 2L-cultures. Bax was expressed for 14 hours (see [28] for a detailed protocol). Briefly, cells were converted to spheroplasts and homogeneized. Two series of low-speed/high-speed centrifugations allowed to obtain a crude mitochondria pellet.
1-3 mg of proteins from cell lysate or isolated mitochondria (10mg/mL) were layered on the top of a 10 mL-density gradient in Beckmann SW41 tubes. Both sucrose and Optiprep (Stemcell Technologies) gradients were done (see results). Gradients were centrifuged overnight at 135,000 x g (28,000 rpm).
Fractions were recovered with an Auto-densiflow II collector (Buchler), precipitated with 0.3M TCA, washed with 100µL cold acetone and solubilized in Laemmli buffer.
Cytochromes contents of isolated mitochondria were measured by differential redox spectrophotometry in a double-beam spectrophotometer Varian Cary 4000, as described previously [29] .
For western-blots, proteins were separated on 12.5% SDS-PAGE, transferred onto nitrocellulose, Horse radish peroxidase-coupled secondary antibodies (Jackson Laboratories, 1/10,000 dilution) were revealed by ECL (Luminata Forte, Millipore), vizualized with a digital camera (G-Box, Syngene), and quantified using Image J software. Statistical analyzes and figures were done with GraphPad Prism 6 software.
Results and discussion
A substitution P168A stimulates Bax mitochondrial localization and ability to permeabilize the OMM to cytochrome c when expressed in yeast [27, 28] and in glioblastoma cells [30] . Also, purified recombinant Bax-P168A was more efficient than the wild-type protein to permeabilize isolated yeast or human mitochondria [31] . The difference between the two proteins was largely attenuated when assayed on liposomes [31] suggesting that additional components were needed to emphasize the distinct activities of the two proteins. Interestingly, a mutant P168G forms stable dimers not inserted into the mitochondrial membrane [32] . This substitution does not simply change the position of the hydrophobic helix α9, but has more general effects on the whole conformation of Bax [33] .
Considering these data, we studied whether other factors that have not been considered until now could be involved in the ability of Bax-P168A to interact with mitochondria.
We built a W303-1B strain carrying a Δmdm34::kanMX4 deletion (that will be named Δmdm34 below). This strain did not exhibit major alterations of cell growth and viability, opposite to mutants carrying deletions of MMM1, MDM10 or MDM12 [25,26;34-37] . Indeed, Δmdm34 grew in YNB supplemented with the non-fermentable carbon source lactate, showing that mitochondria were functionnal. Compared to wild-type, the doubling time was marginally increased (4h15 v/s 4h) and the cell density at the stationnary phase was slightly decreased (2x10 Cellular extracts of the W303-1B and Δmdm34 strains were analyzed on Optiprep density gradients (Fig.1) . Differences between the two strains were in line with the expected phenotype of Δmdm34. In wild-type extracts, a minor population of ER (vizualized by the presence of Dpm1) was found at a higher density (around fraction 12) than the main ER population (fractions 3-8). This fraction was absent from Δmdm34 extracts. However, fractions containing mitochondrial proteins (Por1 and Cox2)
were found at lower densities in Δmdm34 (fractions 10-17) than in wild-type (12) (13) (14) (15) (16) (17) . Consequently, the Δmdm34 strain still contained fractions where ER and mitochondrial proteins were both present (namely fraction 10), albeit at a lower density than in wild-type (fractions 12-13).
To test the involvement of these modifications on Bax relocation and activity, the mutant Bax-P168A was comparatively expressed in wild-type and Δmdm34 yeast strains. In yeast, the activity of Bax is quantitatively measured through the amount of residual mitochondrial cytochrome c by redox spectrophotometry: less mitochondrial cytochrome c indicates a higher Bax activity. The activity of Bax-P168A was slightly but significantly decreased when expressed in Δmdm34 strain (Fig.2A) . The coexpression of the anti-apoptotic protein Bcl-xL partially inhibited Bax-P168A-induced cytochrome c release (Fig.2B) , and abolished the difference between both strains, showing that the initial difference actually reflected an alteration of Bax-P168A activity and not a general property of Δmdm34 mitochondria. Cell extracts from both strains expressing Bax-P168A were analyzed on sucrose density gradients. Although sucrose-based gradients showed more cross-contamination than Optiprep-based gradients, they provided a better discrimination between ER-containing fractions in wild-type and Δmdm34 strains (Fig.2C) . Under these conditions, a population of Bax-P168A was associated to ER in Δmdm34 strain (fraction 4) but not in wild-type (Fig.2C) . This suggested that some Bax-P168A remained associated to the ER compartment, resulting in the decreased ability to release cytochrome c.
Ser184 is located in the helix α9 of Bax, and is the target of several kinases, including AKT [38, 39] .
The phosphorylation of Bax by AKT impairs Bax action on mitochondria, but the underlying mechanisms are not completely clear, as they depend on the presence of anti-apoptotic proteins [40, 41] .
However, there is a consensus about the consequences of substitutions of this residue on Bax localization: Bax-S184D remains mostly cytosolic (and is rapidly degraded when expressed in yeast), while Bax-S184V (or Bax-S184A) is markedly associated to mitochondria (including in yeast).
Although being largely mitochondrial, Bax-S184V was less efficient than Bax-P168A to promote the release of cytochrome c, like previously reported [40] . Furthermore, it was less efficient when expressed in Δmdm34 strain than in the wild-type strain, suggesting that the Δmdm34 deletion had a stronger effect on Bax-S184V than on Bax-P168A (Fig.3A) . As negative controls, Δmdm34 strain that did not express Bax, or that expressed BaxWT (which, like in non-apoptotic mammalian cells, is poorly mitochondrial), did not show any difference in residual mitochondrial cytochrome c, in comparison to wild-type.
We next analyzed the distribution of crude mitochondria preparations of strains expressing Bax-P168A
and Bax-S184V on density gradients (Fig.3B) . Like for gradients of whole cells extracts, we observed that mitochondria-rich fractions (containing Por1), were less dense in Δmdm34 strain (around fraction 6) than in the wild-type strain (around fraction 7).
The distribution of Bax-P168A was not dramatically altered by the Δmdm34 mutation, with a marginal inversion between the two major Bax-containing fractions (6 and 7). The Δmdm34 mutation slightly retained Bax-P168A in the ER (Fig.2C and 3B ) but enough protein remained able to reach the mitochondria to promote a significant release of cytochrome c, although slightly lower than in the wildtype strain (Fig.3A) .
The change in the distribution of Bax-S184V was more dramatic, with a marked shift towards lower densities fractions (5 and 6). It is noteworthy that fraction 5, that contained 40% of total Bax-S184V present in the crude fraction, contained 40% of total Dpm1, but less than 30% of Por1, suggesting that a significant proportion of Bax-S184V remained localized in ER membranes associated to the crude mitochondrial fraction: this correlates with the total loss of capacity of Bax-S184V to release cytochrome c in Δmdm34 strain (Fig.3A) .
Experiments reported above showed that MAMs stability affect, albeit moderatly, the mitochondrial localization of Bax and its capacity to release cytochrome c. We next adressed whether cytochrome c 6 release was, by itself, affected by MAMs stability. Our hypothesis was that, following Bax expression, the mitochondrial fraction might contain two pools of cytochrome c: unreleased cytochrome c genuinely localized in the intermembrane space or 'uncompletely released' cytochrome c that was not anymore in the intermembrane space but not yet in the cytosol, and that was trapped in ER membranes associated to mitochondria. To discriminate between these pools, we compared the level of reduction by dithionite, a chemical reducer, with the level of reduction by NADH, a substrate of the yeast respiratory chain, that is oxidized by two intermembrane space-facing NADH dehydrogenases, thus able to reduce only cytochrome c localized within the intermembrane space [42] .
On wild-type mitochondria, as expected, 100% of cytochrome c reduced by dithionite was also reduced by NADH (Fig.4A) . However, on mitochondria isolated from the strain expressing Bax-P168A, a significant proportion of cytochrome c reduced by dithionite was not reduced by NADH (Fig.4A) . This showed the existence of a pool of cytochrome c, still present in the mitochondrial fraction but not in the intermembrane space, thus not able to receive electrons transferred from Complex III. We next tested whether there was a difference between wild-type and Δmdm34 strains. To attenuate the effect of variations in purity between mitochondrial preparations, we corrected the reduction of cytochrome c by the reduction of cytochrome b, an unreleased integral membrane protein (Fig.4B) . There was no difference between wild-type and Δmdm34 control strains, showing that, in the absence of Bax, all cytochrome c remained within the intermembrane space. There was also no difference between wildtype and Δmdm34 strains expressing Bax-P168A. As reported above (Fig.4A) , a fraction of cytochrome c was not reducible by NADH: Fig.4B showed that the size of this fraction was the same in wild-type and Δmdm34. We found a different behaviour in strains expressing Bax-S184V: the size of the NADHreducible pool was decreased in the wild-type, and significantly re-increased in Δmdm34 (Fig.4B) .
This showed that a pool of non NADH-reducible cytochrome c remained in the mitochondrial fraction following the expression of Bax-S184V, and disappeared in the Δmdm34 strain: this uncompletely released pool of cytochrome c was thus dependent on MAMs stability. Supporting this hypothesis, in mitochondria preparations from wild-type cells expressing Bax-S184V, but not in Δmdm34 expressing Bax-S184V, some cytochrome c was found in lower density fractions, that may correspond to the partly or incompletely released cytochrome c identified by spectrometry (Fig.4C ).
Data reported above show that, in a model cellular system, the interaction of Bax with mitochondria is modulated by the stability of MAMs. The effects of MDM34 deletion on MAMs stability only marginally affected cell growth and viability, contrary to the deletion of the three other ERMES components. This is in line with the proposed model for ERMES organization, where the absence of MDM34 would have less dramatic effects on the complex organization than the absence of any of the three other ones [17] . In spite of this moderate effect on MAMs stability, MDM34 deletion was sufficient to alter the behavior of both Bax-P168A and Bax-S184V mutants.
Both mutants display a strong mitochondrial localization, but not the same level of activity. Bax-P168A is very active, as evidenced by a high ratio of cytochrome c release [28, 30, 31] . On the opposite, the activity of Bax-S184V is modest [28, 40] , particularly in regard to its high mitochondrial content, suggesting that its intrinsic activity is low [29, 40] . The consequences of MDM34 deletion were thus more visible on Bax-S184V than on Bax-P168A, both in terms of Bax localization and of capacity to release cytochrome c. This revealed an unexpected aspect of Bax function: a fraction of cytochrome c that was still present in the crude mitochondrial fraction, could not be reduced by the respiratory substrate NADH. This pool of cytochrome c was detected by spectrophotometry, showing its full assembly with the haem moiety, a process taking place within mitochondria ( [43] for review), and eliminating the hypothesis that it was a pool of cytochrome c not reaching mitochondria. It was therefore a pool of released cytochrome c, that remained yet associated to mitochondria. This fraction of cytochrome c likely corresponds to that was detected by western-blots in lower density fractions.
Interestingly, both NADH reduction and western-blots showed that the size of this fraction was markedly decreased in Δmdm34, evidencing that this fraction of incompletely released cytochrome c was actually located in MAMs.
These data show that, in a model cellular system, both Bax relocation to mitochondria and cytochrome c release to the cytosol depend on the stability of MAMs, suggesting that this compartment may play a role in the regulation of Bax activity during apoptosis. These observations should now be extended to mammalian cells where it is, however, more difficult to modulate MAMs stability without affecting other processes relevant to apoptosis.
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